ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Lecanemab Homecare Service

University College London Hospitals NHS FT · compiled

Tender information last checkedLast checked 29 Sept 2026, 21:44.

Opportunity overview

Direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only.

Classification

  • CPV85149000 — Pharmacy services

Lots

  • The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service.Value not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-04e3d2
Status
active
Has Recurrence
No
Procurement Method
open
Main Procurement Category
services
Procurement Method Details
Open procedure

Covered By

GPA

Bid Opening

Date
19 Feb 2025, 12:00

Legal basis

Id
32014L0024
Scheme
CELEX

Expected award period

Starts
19 Feb 2025, 12:00

Tender Period

Ends
26 Mar 2025

Communication

Classification

Id
85149000
Scheme
CPV
Description
Pharmacy services

Submission terms

Languages

en

Bid Validity Period

Ends
26 Mar 2025, 23:59

Submission Method

electronicSubmission
written

Lots and requirements

Entry 1
Id
1
Status
active
Has Options
No
Has Renewal
No
Description
The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service.

Contract period

Duration In Days
720

Submission terms

Variant Policy
notAllowed

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKI3

Buyer, suppliers and contacts

Organisation 1
Id
GB-FTS-14675
Name
University College London Hospitals NHS FT

Roles

buyer

Address

Region
UKI31
Locality
London
Postal Code
NW1 2PG
Country Name
United Kingdom
Street Address
250 Euston Road

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Legal Name
University College London Hospitals NHS FT

Contact

Name
Aaron Monaghan
Organisation 2
Id
GB-FTS-114660
Name
Royal Courts of Justice

Roles

reviewBody

Address

Locality
London
Postal Code
WC2A 2LL,
Country Name
United Kingdom
Street Address
Strand

Details

Identifier

Legal Name
Royal Courts of Justice

Recorded locations

  • Buyer location · London · UKI31 · NW1 2PG · United Kingdom
  • Delivery location · UKI3

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-04e3d2-2025-02-19T11:33:24Zcompiled ·